← Back to Search

Deprescribing Education for Dementia (STOP-FALLS-D Trial)

N/A

Waitlist Available

Led By Elizabeth Phelan, MD

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, up to 6 months

Awards & highlights

STOP-FALLS-D Trial Summary

This trial aims to help patients and their carers reduce use of CNS drugs, reducing falls and injuries.

Who is the study for?

This trial is for older adults with dementia who are patients at a Kaiser Permanente Washington clinic and have been on CNS-active medications for over three months. It aims to help them, along with their caregivers and doctors, reduce medication use that could lead to falls.Check my eligibility

What is being tested?

The STOP Falls D Educational Intervention is being tested. This program educates dementia patients, their care partners, and primary care providers about the risks of certain medications and how to work together to prevent falls.See study design

What are the potential side effects?

Since this intervention involves education rather than medication, there are no direct side effects like those from drugs. However, changes in medication regimens may cause withdrawal symptoms or other medical issues.

STOP-FALLS-D Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, up to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, up to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Medically treated falls

Secondary outcome measures

All-cause emergency department visit or hospitalization

Skilled nursing facility placement

STOP-FALLS-D Trial Design

1Treatment groups

Experimental Treatment

Group I: Educational InterventionExperimental Treatment1 Intervention

Educational Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor

1,738 Previous Clinical Trials

1,844,226 Total Patients Enrolled

19 Trials studying Dementia

6,738 Patients Enrolled for Dementia

National Institute on Aging (NIA)NIH

1,669 Previous Clinical Trials

28,004,989 Total Patients Enrolled

265 Trials studying Dementia

23,623,286 Patients Enrolled for Dementia

Elizabeth Phelan, MDPrincipal InvestigatorUniversity of Washington

Media Library

STOP Falls D Educational Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05777772 — N/A

Dementia Research Study Groups: Educational Intervention

Dementia Clinical Trial 2023: STOP Falls D Educational Intervention Highlights & Side Effects. Trial Name: NCT05777772 — N/A

STOP Falls D Educational Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05777772 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings available in this investigation for volunteers?

"The clinical trial data hosted on clinicaltrials.gov indicates that this study is no longer recruiting participants, as the posting was last updated on March 8th 2023. While participation for this specific trial has closed, 404 other studies are currently open to patients at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Deprescribing to Reduce Injurious Falls Among Older Adults With Dementia

Elizabeth Phelan 2023. "Deprescribing to Reduce Injurious Falls Among Older Adults With Dementia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05777772.

All > Dementia